CN108283314A - One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof - Google Patents
One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof Download PDFInfo
- Publication number
- CN108283314A CN108283314A CN201711289821.1A CN201711289821A CN108283314A CN 108283314 A CN108283314 A CN 108283314A CN 201711289821 A CN201711289821 A CN 201711289821A CN 108283314 A CN108283314 A CN 108283314A
- Authority
- CN
- China
- Prior art keywords
- group
- substance
- preparation
- glutamine
- 60min
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 230000036541 health Effects 0.000 title claims abstract description 13
- -1 branched-chain amino acid compound Chemical class 0.000 title claims abstract description 11
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 title claims description 30
- 229930182816 L-glutamine Natural products 0.000 title claims description 27
- 239000000843 powder Substances 0.000 claims abstract description 38
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000003756 stirring Methods 0.000 claims abstract description 30
- 239000000126 substance Substances 0.000 claims abstract description 30
- 238000002156 mixing Methods 0.000 claims abstract description 16
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 claims abstract description 15
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 14
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 13
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 13
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 13
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 13
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 13
- 235000013305 food Nutrition 0.000 claims abstract description 13
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 12
- 235000019674 grape juice Nutrition 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229920001353 Dextrin Polymers 0.000 claims abstract description 10
- 239000004375 Dextrin Substances 0.000 claims abstract description 10
- 229930091371 Fructose Natural products 0.000 claims abstract description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 10
- 239000005715 Fructose Substances 0.000 claims abstract description 10
- 235000019425 dextrin Nutrition 0.000 claims abstract description 10
- 239000000796 flavoring agent Substances 0.000 claims abstract description 10
- 235000019634 flavors Nutrition 0.000 claims abstract description 10
- 239000001509 sodium citrate Substances 0.000 claims abstract description 10
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 10
- 239000008223 sterile water Substances 0.000 claims abstract description 10
- 235000020985 whole grains Nutrition 0.000 claims abstract description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 4
- 239000004474 valine Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- AGPKZVBTJJNPAG-UHNVWZDZSA-N L-allo-Isoleucine Chemical compound CC[C@@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-UHNVWZDZSA-N 0.000 claims 1
- 229930182844 L-isoleucine Natural products 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract description 5
- 238000007873 sieving Methods 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000001151 other effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 19
- 229940024606 amino acid Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 150000005693 branched-chain amino acids Chemical class 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-J NADPH(4-) Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OC[C@@H]2[C@H]([C@@H](OP([O-])([O-])=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-J 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000003870 intestinal permeability Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Present specification belongs to health-related field of food, discloses a kind of preparation method of glutamine containing L and three branched-chain amino acid compound health products comprising following steps：1) L glutamine, BCAA, fructose, grape juice, medlar powder, kudzu-vine root powder, tangerine peel powder and Vc are taken, is placed in the first mixer, mixes well, obtains first group of substance；2) citric acid, sodium citrate and food flavor are taken, is placed in the second mixer, mixes well, obtains second group of substance；3) it by first group of substance and second group of material mixing, stirs evenly, then adds sterile water, be heated to 40 50 DEG C while stirring, then dextrin is added, continues to stir 30 60min under heat-retaining condition, then stand 60min, squeezes sieving, dry 30 60min, whole grain to get.The present invention uses the formula of science, has apparent synergistic effect between each component, has and improve immunity and other effects.
Description
Technical field
The present invention relates to one kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof, belongs to guarantor
Strong based food field.
Background technology
L-Glutamine (L-Gln) also known as left-handed bran glutamine are that mammal and the indispensable conditionity of human body must
Need amino acid.L-Glutamine is helpful to the rehabilitation of enteritis, stomach ulcer and angioleucitis patient, it may also be used for enhancing is big
Brain function, auxiliary treatment is retarded, muscular dystrophy and alcoholism etc..
In terms of enteron aisle, supplemented with exogenous L-Glutamine can provide the energy for intestinal mucosa cell, increase and be damaged intestines
The blood flow in road promotes the increase of prostaglandin and stomach lining mucous secretion amount, promotes to repair intestinal mucosa cell, keeps viscous
Membrane structure is complete, prevents gut atrophy.L-Glutamine can also maintain the intestinal permeability of patients with severe pancreatitis, prevent intestines
Transposition occurs for road bacterium, inhibits release inflammatory mediator, the stress reaction of body is made to mitigate, promote patients ' recovery.
In terms of liver protecting, L-Glutamine can be that liver synthesizes oxidation-reduction resistance substance glutathione (GSH)
Pidolidone is provided, if L-Glutamine shortage cannot play the role of being effectively protected to liver function.L-Glutamine may be used also
To promote lipid material in liver to decompose, effectively prevents fatty liver and generate.
In terms of immune response, L-Glutamine can generate reduced-NADP H in metabolic process, so as to promote
Various immune cell propagations and secretion are lymphocytes by the necessary material that cell Proliferation occurs when antigenic stimulus, L- paddy ammonia
The immunocompetence of body can also weaken when amide is horizontal relatively low.
Three branched-chain amino acids, abbreviation BCAA are L-Leu: l-Isoleucine: three kinds of amino acid of Valine press 2: 1: 1
Ratio mix, BCAA can promote protein anabolism after exercise, accelerate muscle synthesis, reduce musculature
It decomposes, helps to increase muscle.Meanwhile or in vivo skeletal muscle energy supply primary amino acid.
Invention content
It is an object of the invention to overcome current technical defect, to solve current market sales of compound amino acid
The shortcomings of electuary dissolving is slow, poor taste, both effectiveness unobvious provides and a kind of containing L-Glutamine and the compound guarantor of three branched-chain amino acids
Strong product and preparation method thereof.
The present invention is achieved by the following technical solution：
A kind of preparation method containing L-Glutamine and three branched-chain amino acid compound health products comprising following steps：
1) L-Glutamine, BCAA, fructose, grape juice, medlar powder, kudzu-vine root powder, tangerine peel powder and Vc are taken, is placed in first
It in mixer, mixes well, obtains first group of substance；
2) citric acid, sodium citrate and food flavor are taken, is placed in the second mixer, mixes well, obtains second group
Substance；
3) it by first group of substance and second group of material mixing, stirs evenly, then adds sterile water, be heated to while stirring
40-50 DEG C, dextrin is then added, continues to stir 30-60min under heat-retaining condition, then stand 60min, squeezes sieving, dry 30-
60min, whole grain to get.
Further,
The preparation method includes the following steps：
1) by L-Glutamine 25-35kg, BCAA 15-25kg, fructose 10-20kg, grape juice 10-15kg, medlar powder
5-10kg, kudzu-vine root powder 2-5kg, tangerine peel powder 2-5kg, Vc 2-5kg, are placed in the first mixer, mix well, obtain first group
Substance；
2) citric acid 0.05-0.1kg, sodium citrate 0.05-0.15kg, food flavor 0.01-0.03kg are placed in second
It in mixer, mixes well, obtains second group of substance；
3) it by first group of substance and second group of material mixing, stirs evenly, is then settled to 100L, side stirring with sterile water
While being heated to 40-50 DEG C, 6-7kg dextrin is then added, continues to stir 30-60min under heat-retaining condition, then stand 60min, squeeze
Cross 20-30 mesh sieve, 60 DEG C of dry 30-60min, whole grain to get.
Further,
The preparation method includes the following steps：
1) by L-Glutamine 25kg, BCAA 20kg, fructose 15kg, grape juice 10kg, medlar powder 10kg, kudzu-vine root powder
2kg, tangerine peel powder 2kg, Vc 2kg, is placed in the first mixer, mixes well, and obtains first group of substance；
2) citric acid 0.05kg, sodium citrate 0.1kg, food flavor 0.01kg are placed in the second mixer, it is fully mixed
It is even, obtain second group of substance；
3) it by first group of substance and second group of material mixing, stirs evenly, is then settled to 100L, side stirring with sterile water
While being heated to 40 DEG C, 6kg dextrin is then added, continues to stir 30min under heat-retaining condition, then stand 60min, squeezed 30 mesh
Sieve, 60 DEG C of dry 30min, whole grain to get.
Further,
The BCAA is by L-Leu: l-Isoleucine: Valine is obtained by mixing by 2: 1: 1 mass ratio.
The compound health products prepared according to the above-mentioned preparation method being allowed to described in one are also claimed in the present invention.
Beneficial effects of the present invention are main but are not limited to the following aspects：
The present invention uses the formula of science, has apparent synergistic effect between each component, have rise the strong liver of flesh, refresh oneself it is awake
Brain, raising immunity, holding intestinal health and other effects, meanwhile, excellent taste abundant with taste, edible safety, convenient, guarantor
The matter phase is long, easy to carry, and target user is extensive, effect stability, is suitble to large-scale production；
In preparation process of the present invention, using respectively by more than mass fraction or raw material that mass fraction is few is pre-mixed, so
It is mixed again afterwards, ensures that raw material can be sufficiently mixed uniformly；
The adequate nutrition supply of protein is to maintain the material base of Cellular Immunity and humoral immunity ability, amino acid
It is the base unit for constituting protein, selects that compound amino acid is used to meet nutrition, battalion as ingredient the effect of improving immunity
Support immunology basic theories and application practice, the present invention is arranged in pairs or groups health care food materials by amino acid needed by human, using rationally matching
Side and technique, the product of preparation achieve the effect that enhance immunity, zoopery prompt, each raw material collaboration in product of the present invention
Effect is good, can significantly improve mouse lymphocyte proliferation.
Specific implementation mode
In order to make those skilled in the art better understand the technical solutions in the application, having below in conjunction with the application
Body embodiment more clearly and completely describes the present invention, it is clear that described embodiment is only the application one
Divide embodiment, instead of all the embodiments.Based on the embodiment in the application, those of ordinary skill in the art are not making
The every other embodiment obtained under the premise of creative work, should all belong to the scope of protection of the invention.
Experimental method used in following embodiments is conventional method unless otherwise specified.
Raw material used in following embodiments, is commercially available unless otherwise specified.
Embodiment 1
A kind of preparation method containing L-Glutamine and three branched-chain amino acid compound health products comprising following steps：
By L-Glutamine 25kg, and BCAA (three branched-chain amino acids, by L-Leu: l-Isoleucine: Valine presses 2:
1: 1 mass ratio is obtained by mixing) 20kg, fructose 15kg, grape juice 10kg, medlar powder 10kg, kudzu-vine root powder 2kg, tangerine peel powder
2kg, Vc (vitamin C) 2kg, is placed in the first mixer, mixes well, and obtains first group of substance；
Citric acid 0.05kg, sodium citrate 0.1kg, food flavor 0.01kg are placed in the second mixer, it is fully mixed
It is even, obtain second group of substance；
It by first group of substance and second group of material mixing, stirs evenly, is then settled to 100L with sterile water, while stirring
40 DEG C are heated to, 6kg dextrin is then added, continues to stir 30min under heat-retaining condition, then stand 60min, keeps it internal full of more
And close hole, enlarged volume, quality are soft, squeeze sieving (30 mesh), 60 DEG C of dry 30min, whole grain to get.
The amount of application of product of the present invention：Each adult daily 1 time, each 10-20g.
Embodiment 2
A kind of preparation method containing L-Glutamine and three branched-chain amino acid compound health products comprising following steps：
By L-Glutamine 30kg, BCAA 15kg, fructose 10kg, grape juice 10kg, medlar powder 6kg, kudzu-vine root powder 3kg,
Tangerine peel powder 3kg, Vc 3kg, is placed in the first mixer, mixes well, and obtains first group of substance；
Citric acid 0.1kg, sodium citrate 0.1kg, food flavor 0.02kg are placed in the second mixer, are mixed well,
Obtain second group of substance；
It by first group of substance and second group of material mixing, stirs evenly, is then settled to 100L with sterile water, while stirring
37 DEG C are heated to, 7kg dextrin is then added, continues to stir 40min under heat-retaining condition, then stand 60min, keeps it internal full of more
And close hole, enlarged volume, quality are soft, squeeze sieving (20 mesh), 60 DEG C of dry 30min, whole grain to get.
The amount of application of product of the present invention：Each adult daily 1 time, each 10-20g.
Embodiment 3
A kind of preparation method containing L-Glutamine and three branched-chain amino acid compound health products comprising following steps：
By L-Glutamine 28kg, BCAA 18kg, fructose 12kg, grape juice 12kg, medlar powder 8kg, kudzu-vine root powder 3kg,
Tangerine peel powder 2kg, Vc 2kg, is placed in the first mixer, mixes well, and obtains first group of substance；
Citric acid 0.05kg, sodium citrate 0.15kg, food flavor 0.01kg are placed in the second mixer, it is fully mixed
It is even, obtain second group of substance；
It by first group of substance and second group of material mixing, stirs evenly, is then settled to 100L with sterile water, while stirring
38 DEG C are heated to, 6.5kg dextrin is then added, continues to stir 50min under heat-retaining condition, then stand 60min, makes to be full of inside it
More and close holes, enlarged volume, quality is soft, squeeze sieving (30 mesh), 60 DEG C of dry 30min, whole grain to get.
The amount of application of product of the present invention：Each adult daily 1 time, each 10-20g.
Embodiment 4
The performance measurement of product prepared by 1-3 of the embodiment of the present invention：
After testing, the obtained product particle of the present invention is uniform in size, and color and luster is consistent, is in uniform color and luster after dissolving gelatinization.This hair
It is bright also to have detected dissolution time, it imposes a condition under conditions of water temperature is 30 DEG C, 120rpm is stirred, to be arranged in 500ml water and adding
Add 10g, is compared with Instant branched-chain amino acid, as shown in table 1 below.
Table 1
Conclusion：As shown in table 1, compared with Instant branched-chain amino acid, product dissolving prepared by 1-3 of the embodiment of the present invention is fast
Degree is higher, and turbidity is low, is in uniform color and luster after dissolving gelatinization, market application prospect is wide.
Embodiment 5
Influence of the product of the present invention to mouse lymphocyte：
Trial product to be measured：Embodiment 1；Reference examples 1：Glutamine is not added, the amount of glutamine uses BCAA polishings,
Remaining same embodiment 1；Reference examples 2：Do not add grape juice and medlar powder, the amount of grape juice and medlar powder is mended using kudzu-vine root powder
Together, remaining is the same as embodiment 1；Reference examples 3：Do not add kudzu-vine root powder and tangerine peel powder, the amount of kudzu-vine root powder and tangerine peel powder uses medlar powder
Polishing, remaining is the same as embodiment 1.
Experiment process：Kunming kind female mice, weight 18g-22g.Each group takes 30 mouse, is divided into 5 groups, respectively
1 group of embodiment, reference examples 1-3 groups, blank control group.Edible daily primary, each dosage is 10mg, and blank control group eats phase
The physiological saline of homogenous quantities, it is continuous two weeks edible.
It is sterile to take spleen, cell suspension, living cell counting number is made, adjustment cell concentration is 5 × 106A/mL, cell is hanged
During liquid divides holes to be added, per hole 1mL, a hole adds 75 μ L of ConA liquid wherein, and 5% carbon dioxide as a contrast, is set in another hole, and 37
DEG C culture 72h.Culture terminates preceding 4h, and supernatant 0.7mL is gently sucked per hole, and 0.7mL is added and is free of calf serum
RPMI1640 culture solutions, while the holes MTT50uL/ are added, continue to cultivate 4h.After culture, 1mL acid isopropyls are added per hole
Alcohol blows and beats mixing, purple crystal is made to be completely dissolved.Then it is dispensed into 96 well culture plates, 3 parallel holes are made in each hole, use enzyme
Instrument is marked, the OD value at 570nm wavelength is surveyed.The proliferative capacity of lymphocyte with plus the OD value in the holes ConA subtract and be not added with
The OD value in the holes ConA indicates.
Same procedure has detected influence of the high dose group (dosage 50mg) to lymphopoiesis ability.
Influence of each group product to mouse lymphocyte proliferative capacity is as shown in table 2.
Table 2
Conclusion：As shown in Table 2, compared with blank control group, 1 group of embodiment and control group 1-3 groups can improve lymph
The effect of stimulation of ability of cell proliferation, embodiment 1 is better than control group 1-3, and each raw material in embodiment 1 is prompted to have preferable collaboration
Effect, and the effect of high dose group is better than low dose group.
Listed above is only the best specific embodiment of the present invention.It is clear that the invention is not restricted to which above example, may be used also
With there are many deformations.All changes that those skilled in the art directly can export or associate from present disclosure
Shape is considered as protection scope of the present invention.
Claims (5)
1. a kind of preparation method containing L-Glutamine and three branched-chain amino acid compound health products comprising following steps：
1) L-Glutamine, BCAA, fructose, grape juice, medlar powder, kudzu-vine root powder, tangerine peel powder and Vc are taken, the first mixing is placed in
It in device, mixes well, obtains first group of substance；
2) citric acid, sodium citrate and food flavor are taken, is placed in the second mixer, mixes well, obtains second group of substance；
3) it by first group of substance and second group of material mixing, stirs evenly, then adds sterile water, be heated to 40-50 while stirring
DEG C, dextrin is then added, continues to stir 30-60min under heat-retaining condition, then stand 60min, squeezes and be sieved, dry 30-60min,
Whole grain to get.
2. preparation method according to claim 1, which is characterized in that the preparation method includes the following steps：
1) by L-Glutamine 25-35kg, BCAA 15-25kg, fructose 10-20kg, grape juice 10-15kg, medlar powder 5-
10kg, kudzu-vine root powder 2-5kg, tangerine peel powder 2-5kg, Vc 2-5kg, are placed in the first mixer, mix well, and obtain first group of object
Matter；
2) citric acid 0.05-0.1kg, sodium citrate 0.05-0.15kg, food flavor 0.01-0.03kg are placed in the second mixing
It in device, mixes well, obtains second group of substance；
3) it by first group of substance and second group of material mixing, stirs evenly, is then settled to 100L with sterile water, add while stirring
Then 6-7kg dextrin is added to 40-50 DEG C in heat, continue to stir 30-60min under heat-retaining condition, then stand 60min, squeeze
20-30 mesh sieve, 60 DEG C of dry 30-60min, whole grain to get.
3. preparation method according to claim 2, which is characterized in that the preparation method includes the following steps：
1) by L-Glutamine 25kg, BCAA 20kg, fructose 15kg, grape juice 10kg, medlar powder 10kg, kudzu-vine root powder 2kg,
Tangerine peel powder 2kg, Vc 2kg, is placed in the first mixer, mixes well, and obtains first group of substance；
2) citric acid 0.05kg, sodium citrate 0.1kg, food flavor 0.01kg are placed in the second mixer, are mixed well,
Obtain second group of substance；
3) it by first group of substance and second group of material mixing, stirs evenly, is then settled to 100L with sterile water, add while stirring
Then 6kg dextrin is added to 40 DEG C in heat, continue to stir 30min under heat-retaining condition, then stand 60min, squeezed 30 mesh and sieves, and 60
DEG C dry 30min, whole grain to get.
4. according to the preparation method described in claim 1-3, which is characterized in that the BCAA is by L-Leu：L-Isoleucine：
Valine is obtained by mixing by 2: 1: 1 mass ratio.
5. being allowed to the compound health products of the preparation of the preparation method described in one according to claim 1-4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711289821.1A CN108283314A (en) | 2017-11-30 | 2017-11-30 | One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711289821.1A CN108283314A (en) | 2017-11-30 | 2017-11-30 | One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108283314A true CN108283314A (en) | 2018-07-17 |
Family
ID=62831674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711289821.1A Pending CN108283314A (en) | 2017-11-30 | 2017-11-30 | One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108283314A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030119888A1 (en) * | 1991-11-20 | 2003-06-26 | Allen Ann De Wees | Composition comprising l-arginine as a muscle growth stimulant and use thereof |
| CN102512655A (en) * | 2011-11-30 | 2012-06-27 | 北京康比特体育科技股份有限公司 | L-carnitine composition, L-carnitine preparation and preparation method and application thereof |
| CN102771690A (en) * | 2012-07-06 | 2012-11-14 | 张文彪 | Muscle building functional food |
| CN103734716A (en) * | 2013-12-16 | 2014-04-23 | 无锡金维氨生物科技有限公司 | Branched chain amino acid |
| CN106420629A (en) * | 2016-10-28 | 2017-02-22 | 广州中大南沙科技创新产业园有限公司 | Branched chain amino acid preparation and preparation method and application thereof |
| CN106605908A (en) * | 2016-05-27 | 2017-05-03 | 韶关邦世迪健康实业有限公司 | Fully nutritional formula product with special medical purposes for liver diseases |
| CN106720373A (en) * | 2016-12-02 | 2017-05-31 | 南通励成生物工程有限公司 | A kind of anti-fatigue solid beverage and preparation method thereof |
-
2017
- 2017-11-30 CN CN201711289821.1A patent/CN108283314A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030119888A1 (en) * | 1991-11-20 | 2003-06-26 | Allen Ann De Wees | Composition comprising l-arginine as a muscle growth stimulant and use thereof |
| CN102512655A (en) * | 2011-11-30 | 2012-06-27 | 北京康比特体育科技股份有限公司 | L-carnitine composition, L-carnitine preparation and preparation method and application thereof |
| CN102771690A (en) * | 2012-07-06 | 2012-11-14 | 张文彪 | Muscle building functional food |
| CN103734716A (en) * | 2013-12-16 | 2014-04-23 | 无锡金维氨生物科技有限公司 | Branched chain amino acid |
| CN106605908A (en) * | 2016-05-27 | 2017-05-03 | 韶关邦世迪健康实业有限公司 | Fully nutritional formula product with special medical purposes for liver diseases |
| CN106420629A (en) * | 2016-10-28 | 2017-02-22 | 广州中大南沙科技创新产业园有限公司 | Branched chain amino acid preparation and preparation method and application thereof |
| CN106720373A (en) * | 2016-12-02 | 2017-05-31 | 南通励成生物工程有限公司 | A kind of anti-fatigue solid beverage and preparation method thereof |
Non-Patent Citations (5)
| Title |
|---|
| 国家中医药管理局专业技术资格考试专家委员会: "《中药学》", 31 January 2011, 中国中医药出版社 * |
| 悠扬: "《彩色图解《汤头歌诀》》", 31 August 2015, 北京联合出版公司 * |
| 李永来: "《中华食疗大全》", 30 November 2012, 黑龙江科学技术出版社 * |
| 祝路民，等: "谷氨酞胺复方制剂对晕船大鼠脑体疲劳的影响", 《中华航海医学与高气压医学杂志》 * |
| 齐玉梅: "《特殊医学用途配方食品临床应用参考目录》", 31 August 2017, 中国医药科技出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101647838B (en) | Ginseng donkey-hide gelatin paste preparation technique | |
| CN105558744B (en) | A kind of effervescent tablet and preparation method thereof containing branched-chain amino acid | |
| CN103783532A (en) | Compound protein powder for resisting age-related sarcopenia, and preparation methods thereof | |
| CN103156895A (en) | Anti-fatigue capsule and preparation method for same | |
| CN107568551A (en) | A kind of solid beverage of hippocampus small-molecular peptides compounding and preparation method thereof | |
| CN107712534A (en) | A kind of solid beverage of black soya bean small-molecular peptides compounding and preparation method thereof | |
| TW201417803A (en) | Methods and compositions for increasing sex steroids and growth hormones | |
| CN103584062A (en) | Nutritious low-sodium composite salt and preparation method thereof | |
| CN106262938A (en) | A kind of compositions for physical strength reinforcing and preparation method thereof | |
| CN107581446A (en) | A kind of solid beverage of cherry small-molecular peptides compounding and preparation method thereof | |
| CN108606269A (en) | A kind of sports type nutritional supplement and preparation method thereof | |
| CN105661235A (en) | Beverage for supplementing compound nutrients and production method thereof | |
| CN107616402A (en) | A kind of solid beverage of black rice small-molecular peptides compounding and preparation method thereof | |
| CN103976205B (en) | Endocrine fruit jelly of a kind of improvement and preparation method thereof | |
| CN108283314A (en) | One kind containing L-Glutamine and three branched-chain amino acid compound health products and preparation method thereof | |
| CN105146664A (en) | Dietary fiber beverage and preparation method thereof | |
| CN102028230B (en) | Health care product auxiliary material and application thereof | |
| CN108715785A (en) | A kind of deer placenta wine and preparation method thereof | |
| CN107712517A (en) | A kind of dictyophora phalloidea small-molecular peptides compounding nutrition peptide water beverage and preparation method thereof | |
| CN104082656A (en) | Nutrient meal suitable for patient with liver disease and manufacturing method thereof | |
| CN103875900A (en) | Pig feed containing purple perilla and preparation method thereof | |
| CN108244652A (en) | It is a kind of to be used for energy glue of physical efficiency recovery and preparation method thereof after moving | |
| CN104435003B (en) | A kind of Chinese caterpillar fungus health product preparation and preparation method thereof | |
| CN106666637A (en) | Medicated diet composition for pregnant women and preparation method thereof | |
| CN107259559B (en) | Rapeseed polypeptide and schisandra chinensis aqueous extract and method for synergistically improving sleep |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180717 |
|
| RJ01 | Rejection of invention patent application after publication |